168 related articles for article (PubMed ID: 1845946)
1. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan.
Nishioka K; Watanabe J; Furuta S; Tanaka E; Iino S; Suzuki H; Tsuji T; Yano M; Kuo G; Choo QL
Cancer; 1991 Jan; 67(2):429-33. PubMed ID: 1845946
[TBL] [Abstract][Full Text] [Related]
2. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.
Shiratori Y; Shiina S; Imamura M; Kato N; Kanai F; Okudaira T; Teratani T; Tohgo G; Toda N; Ohashi M
Hepatology; 1995 Oct; 22(4 Pt 1):1027-33. PubMed ID: 7557847
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
Tomimatsu M; Ishiguro N; Taniai M; Okuda H; Saito A; Obata H; Yamamoto M; Takasaki K; Nakano M
Cancer; 1993 Aug; 72(3):683-8. PubMed ID: 8192727
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
5. Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan.
Nishioka K; Watanabe J; Furuta S; Tanaka E; Suzuki H; Iino S; Tsuji T; Yano M; Kuo G; Choo QL
Liver; 1991 Apr; 11(2):65-70. PubMed ID: 1646928
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma.
Ohkoshi S; Kojima H; Tawaraya H; Miyajima T; Kamimura T; Asakura H; Satoh A; Hirose S; Hijikata M; Kato N
Jpn J Cancer Res; 1990; 81(6-7):550-3. PubMed ID: 2169469
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma.
Watanabe Y; Harada S; Saito I; Miyamura T
Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
Tanaka K; Hirohata T; Koga S; Sugimachi K; Kanematsu T; Ohryohji F; Nawata H; Ishibashi H; Maeda Y; Kiyokawa H
Cancer Res; 1991 Jun; 51(11):2842-7. PubMed ID: 1851661
[TBL] [Abstract][Full Text] [Related]
9. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C and B viruses, and their association with hepatocellular carcinoma in Egypt.
Darwish MA; Issa SA; Aziz AM; Darwish NM; Soliman AH
J Egypt Public Health Assoc; 1993; 68(1-2):1-9. PubMed ID: 7504048
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
Yu ZY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of NonBNonC- HCC: Comparison with HBV and HCV related HCC.
Hatanaka K; Kudo M; Fukunaga T; Ueshima K; Chung H; Minami Y; Sakaguchi Y; Hagiwara S; Orino A; Osaki Y
Intervirology; 2007; 50(1):24-31. PubMed ID: 17164554
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
Ozyilkan E; Ozyilkan O; Firat D; Telatar H
Cancer; 1994 Apr; 73(7):2002-3. PubMed ID: 8137230
[No Abstract] [Full Text] [Related]
15. [Type C hepatitis and hepatocellular carcinoma].
Kobayashi K
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1947-52. PubMed ID: 1329669
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.
Weinig M; Hakim JG; Gudza I; Tobaiwa O
Trans R Soc Trop Med Hyg; 1997; 91(5):570-2. PubMed ID: 9463670
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma.
Colombo M; Rumi MG; Donato MF; Tommasini MA; Del Ninno E; Ronchi G; Kuo G; Houghton M
Dig Dis Sci; 1991 Aug; 36(8):1130-3. PubMed ID: 1650689
[TBL] [Abstract][Full Text] [Related]
18. Anti-HCV antibody in Chinese cirrhotic patients with or without hepatocellular carcinoma: relation to multitransfusion.
Chang WY; Wang LY; Chuang WL; Chen SC; Lu SN; You SL
J Gastroenterol Hepatol; 1992; 7(2):128-31. PubMed ID: 1315166
[TBL] [Abstract][Full Text] [Related]
19. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
20. Evolution of prognostic factors in hepatocellular carcinoma in Japan.
Nouso K; Kobayashi Y; Nakamura S; Kobayashi S; Toshimori J; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K
Aliment Pharmacol Ther; 2010 Feb; 31(3):407-14. PubMed ID: 19849688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
